Bernard Greenberg, MD
University of Connecticut Health Center, Farmington, CT
Copyright of the American Society of Hematology, 2006. ISSN: 1931-6860.
This case was reviewed and updated in August 2011 by Dr. Alvin Schmaier and members of the Teaching Cases Subcommittee.
Bartik MM, Welker D, Kay NE. Impairments in immune cell function in B cell chronic lymphocytic leukemia. Semin Oncol. 1998;25:27-33.
Binet JL, Auquier A, Dighiero G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer. 1981;48:198-206.
Cheson BD, Bennett JM, Grever M, et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood. 1996;87:4990-4997.
Gribben JG, O'Brien S. Update on therapy of chronic lymphocytic leukemia. J Clin Oncol. 2011;29:544-550.
Lanasa MC. Novel insights into the biology of CLL. Hematology Am Soc Hematol Educ Program. 2010;2010:70-76.
Montserrat E, Vinolas N, Reverter JC, Rozman C. Natural history of chronic lymphocytic leukemia on the progression and prognosis of early clinical stages. Nouv Rev Fr Hematol. 1988;30:359-361.
Rai KR, Sawitsky A, Cronkite EP, et al. Clinical staging of chronic lymphocytic leukemia. Blood. 1975;46:219-234.
Stilgenbauer S, Zenz T. Understanding and managing ultra high-risk chronic lymphocytic leukemia. Hematology Am Soc Hematol Educ Program. 2010;2010:481-488.
Trump DL, Mann RB, Phelps R, et al. Richter's syndrome diffuse hystiocytic lymphoma in patients with chronic lymphocytic leukemia: a report of five cases and review of the literature. Am J Med. 1980;68:539-548.
Zwiebel JA, Cheson BD. Chronic lymphocytic leukemia staging and prognostic factors. Semin Oncol. 1998;25:42-59.
Have a question or comment about the ASH Teaching Cases? Please e-mail email@example.com.